Related references
Note: Only part of the references are listed.Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps
Thibaut Van Zele et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2014)
The effects of lebrikizumab in patients with mild asthma following whole lung allergen challenge
H. Scheerens et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
OX40L blockade and allergen-induced airway responses in subjects with mild asthma
G. M. Gauvreau et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects
J. P. Arm et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2014)
Management of Chronic Rhinosinusitis in Asthma Patients: Is There Still a Debate?
Eduardo Lehrer et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2014)
Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity
Mahboobeh Mahdavinia et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Efficacy and safety of an anti-IL-13 mAb in patients with severe asthma: A randomized trial
Erika H. De Boever et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gail M. Gauvreau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
Elisabeth H. Bel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
Hector G. Ortega et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production
Gail M. Gauvreau et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
Gennaro D'Amato et al.
MULTIDISCIPLINARY RESPIRATORY MEDICINE (2014)
ICON: chronic rhinosinusitis
Claus Bachert et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2014)
Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti-IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma
William W. Busse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
A phase 1, randomized, placebo-controlled, dose-escalation study of an anti-IL-13 monoclonal antibody in healthy subjects and mild asthmatics
Peter Hodsman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Rationale and Clinical Results of Inhibiting Interleukin-5 for the Treatment of Severe Asthma
Rachid Berair et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2013)
A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma
Edward Piper et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Dose-ranging study of lebrikizumab in asthmatic patients not receiving inhaled steroids
Michael Noonan et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes
Florence E. Roufosse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia
Michel Laviolette et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis
Deepti R. Nagarkar et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Endotypes and phenotypes of chronic rhinosinusitis: A PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology
Cezmi A. Akdis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Inhibiting Interleukin-4 and Interleukin-13 in Difficult-to-Control Asthma
Michael E. Wechsler
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels
Sally Wenzel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy of Anti-Interleukin-5 Therapy with Mepolizumab in Patients with Asthma: A Meta-Analysis of Randomized Placebo-Controlled Trials
Yao Liu et al.
PLOS ONE (2013)
Expression of RANTES, eotaxin-2, ICAM-1, LFA-1 and CCR-3 in chronic rhinosinusitis patients with nasal polyposis
Fransergio Emilio Cavallari et al.
ACTA CIRURGICA BRASILEIRA (2012)
Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor
N. A. Molfino et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2012)
Therapeutic Strategies for Harnessing Human Eosinophils in Allergic Inflammation, Hypereosinophilic Disorders, and Cancer
Zhaleh J. Amini-Vaughan et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2012)
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Ian D. Pavord et al.
LANCET (2012)
Chronic rhinosinusitis: From one disease to different phenotypes
Claus Bachert et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2012)
Chronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
D. Hastan et al.
ALLERGY (2011)
Reslizumab for Poorly Controlled, Eosinophilic Asthma A Randomized, Placebo-controlled Study
Mario Castro et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Role of Thymic Stromal Lymphopoietin in the Pathogenesis of Nasal Polyposis
Tao Liu et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2011)
Stratified medicine in selecting biologics for the treatment of severe asthma
Jaymin B. Morjaria et al.
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Pathogenesis of chronic rhinosinusitis: Inflammation
Koen Van Crombruggen et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Chronic rhinosinusitis: Epidemiology and medical management
Daniel L. Hamilos
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Lebrikizumab Treatment in Adults with Asthma
Jonathan Corren et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Monoclonal antibodies for the treatment of asthma
Matthew C. Catley et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Efficacy of omalizumab in the treatment of nasal polyps
Maria del Carmen Vennera et al.
THORAX (2011)
Increased Expression and Role of Thymic Stromal Lymphopoietin in Nasal Polyposis
Satoko Kimura et al.
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2011)
A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma
Jonathan Corren et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor α antibody, in a phase I study of subjects with mild asthma
William W. Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
MEDI-563, a humanized anti-IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity function
Roland Kolbeck et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma
Claus Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Antibodies specific for a segment of human membrane IgE deplete IgE-producing B cells in humanized mice
Hans D. Brightbill et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma
C. K. Oh et al.
EUROPEAN RESPIRATORY REVIEW (2010)
A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma
Sally E. Wenzel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Chronic rhinosinusitis with and without nasal polyps: What is the difference?
Wouter Huvenne et al.
CURRENT ALLERGY AND ASTHMA REPORTS (2009)
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Pranabashis Haldar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Parameswaran Nair et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma A Randomized, Controlled Trial
William W. Busse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
The role of cytokines in chronic rhinosinusitis with nasal polyps
Bradley A. Otto et al.
CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY (2008)
Anti-IgE (omalizumab): A new therapeutic approach for chronic rhinosinusitis
Sonja A. Grundinann et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Targeting TNF-alpha: A novel therapeutic approach for asthma
Christopher Brightling et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease
Nan Zhang et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Treatment of patients with the hypereosinophilic syndrome with mepolizumab
Marc E. Rothenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma
Patrick Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Effect of an interieukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies
Sally Wenzel et al.
LANCET (2007)
Differentiation of chronic sinus diseases by measurement of inflammatory mediators
T. Van Zele et al.
ALLERGY (2006)
Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps
Philippe Gevaert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Tumour necrosis factor (TNFα) as a novel therapeutic target in symptomatic corticosteroid dependent asthma
PH Howarth et al.
THORAX (2005)
Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy
ST Holgate et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2005)
Anti-interleukin-4 therapy
JW Steinke
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2004)
Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway
PT Flood-Page et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Omalizumab treatment downregulates dendritic cell Fc epsilon F-RI expression
C Prussin et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Effect of omalizumab on symptoms of seasonal allergic rhinitis - A randomized controlled trial
TB Casale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma
W Busse et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Total and specific IgE in nasal polyps is related to local eosinophilic inflammation
C Bachert et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2001)
Share Paper
